Find-Health-Articles.com - making medical research available to everyone
Research article summary (published 18 Aug 2009):

Panic disorder and social anxiety disorder subtypes in a caffeine challenge test.

Full Abstract

Studies have demonstrated the vulnerability of anxiety disorder patients to challenge tests. Our aim was to observe if panic disorder (PD) patients and generalized social anxiety disorder (GSAD) and performance social anxiety disorder (PSAD) patients respond in a similar way to the induction of anxiety symptoms and panic attacks by an oral caffeine challenge test. We compared 28 PD patients, 25 GSAD patients, 19 PSAD, and 26 control subjects after a 480-mg caffeine test. The patients had not received psychotropic drugs for at least a 4-week period. In a randomized double-blind experiment performed in two occasions 7 days apart, 480 mg of caffeine and a caffeine-free solution were administered and anxiety scales were administered before and after each test. A panic attack was induced in 17 (60.7%) PD patients, 4 (16.0%) GSAD patients, and 10 (52.6%) PSAD patients, during the caffeine test. None of the control subjects had a panic attack after the caffeine intake. Neither patients nor any control subject had a panic attack after drinking the caffeine-free solution. Our data suggest that there is an association between PD and PSAD hyperreactivity to an oral caffeine challenge test. The PD and PSAD patients had a higher number of induced panic attacks, some specific anxiety symptoms, and a more severe anxiety response than GSAD patients and normal volunteers.

 

Author information

Author/s: Nardi, Antonio E (AE); Lopes, Fabiana L (FL); Freire, Rafael C (RC); Veras, Andre B (AB); Nascimento, Isabella (I); Valença, Alexandre M (AM); de-Melo-Neto, Valfrido L (VL); Soares-Filho, Gastão L (GL); King, Anna Lucia (AL); Araújo, Daniele M (DM); Mezzasalma, Marco A (MA); Rassi, Arabella (A); Zin, Walter A (WA);

Affiliation: Laboratory of Panic and Respiration, Institute of Psychiatry, Federal University of Rio de Janeiro, R. Visconde de Pirajá, 407/702, Rio de Janeiro, RJ-22410-003 Brazil. antonionardi(-atsign-)terra.com.br

Journal and publication information

Publication Type: Clinical Trial; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't

Journal: Psychiatry research (Psychiatry Res), published in Ireland. (Language: eng)

Reference: 2009-Sep; vol 169 (issue 2) : pp 149-53

Dates: Created 2009/09/07; Completed 2009/10/29;

PMID: 19698996, status: MEDLINE (last retrieval date: 10/29/2009, IMS Date: )

Sourced from the National Library of Medicine. Abstract text and other information may be subject to copyright.

External Links for this article
(including full text providers, if available):

Click Electronic Full-text Provider Links to see options for finding the electronic full text links to this article. Note there may be a subscription or fee required for access to the full text. See our FAQ for information on finding FREE full text articles.

This article may also be located in paper journal collections available in many libraries. Use the Journal and Publication Information above to find the full article.

MeSH headings (categories)

This article was linked to the MESH Headings shown below.

Associated Chemicals: Central Nervous System Stimulants (0) ; Caffeine (58-08-2)

Related articles

These are the highest related articles currently in the database:

See 100+ related articles.

Related Article Map

10/30/1991
6/26/2007
Higher Relevance Score (100)
Lower Relevance Score (76)

Legend: - FREE Full text Article. - Abstract only. - Title only. More help.

See a large map of 100+ related articles.

© Advanogy LLC 2003-2009 - All rights reserved. Terms of Use | Contact Us | Index